MLNT
Melinta Therapeutics, Inc. Common Stock
MLNT
MLNT
Delisted
MLNT was delisted on the 10th of January, 2020.
53 hedge funds and large institutions have $17.8M invested in Melinta Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
14% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 14
Holders
53
Holding in Top 10
–
Calls
$3.13M
Puts
$2.97M
Top Buyers
| 1 | +$1.45M | |
| 2 | +$953K | |
| 3 | +$821K | |
| 4 |
Renaissance Technologies
New York
|
+$772K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$607K |
Top Sellers
| 1 | -$7.66M | |
| 2 | -$2.08M | |
| 3 | -$1.53M | |
| 4 |
DM
Deerfield Management
New York
|
-$1.27M |
| 5 |
State Street
Boston,
Massachusetts
|
-$651K |